News & Events

June 8, 2021

BrainsWay to Present at the Raymond James Human Health Innovation Conference

CRESSKILL, N.J. and JERUSALEM, June 08, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

June 7, 2021

BrainsWay to Present at Clinical TMS Society Annual Meeting and Psych Congress Elevate

CRESSKILL, N.J. and JERUSALEM, Israel, June 7, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

June 2, 2021

BrainsWay Announces Positive OCD Coverage Policy by Blue Cross Blue Shield® Licensee HCSC

HCSC Covers Approximately 17 Million Members Across Five States CRESSKILL, N.J. and JERUSALEM, Israel,...

June 1, 2021

BrainsWay Announces First Draft Proposal for OCD Coverage by a Regional Medicare Administrative Contractor

Palmetto GBA, Administrator of Medicare in Seven States, Publishes Draft Local Coverage Determination CRESSKILL,...

May 24, 2021

BrainsWay Announces First of its Kind Positive Coverage Policy by Centene for the Treatment of OCD Utilizing Deep TMS™

CRESSKILL, N.J. and JERUSALEM, Israel, March 24, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

May 20, 2021

BrainsWay Reports First Quarter 2021 Financial Results and Operational Highlights

*Note, the numbers contained herein reflect certain updates to the previous unaudited financial results...

May 19, 2021

BrainsWay to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit

CRESSKILL, N.J. and JERUSALEM, May 19, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

May 6, 2021

BrainsWay to Report First Quarter 2021 Financial Results on May 20, 2021

CRESSKILL, N.J. and JERUSALEM, Israel, May 6, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...

May 5, 2021

BrainsWay Announces Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Officer

CRESSKILL, N.J. and JERUSALEM, May 05, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

May 4, 2021

BrainsWay Announces Social Media Sweepstakes to Celebrate Mental Health Awareness Month

The Sweepstakes, demonstrating how Deep Transcranial Magnetic Stimulation (Deep TMS) can fit into an...

May 3, 2021

BrainsWay to Ring NASDAQ Closing Bell to Highlight May as Mental Health Awareness Month

CRESSKILL, N.J. and JERUSALEM, May 03, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

April 29, 2021

BrainsWay Announces Launch of Noninvasive Treatment for Smoking Addiction to U.S. Providers

Patients in areas across the country now have access to Deep Transcranial Magnetic Stimulation (Deep...

April 26, 2021

BrainsWay Receives FDA Clearance for Three-Minute Theta Burst Treatment Protocol for Major Depressive Disorder

Shorter Protocol Further Expands Access to Care CRESSKILL, N.J. and JERUSALEM, April 26, 2021 (GLOBE...

April 14, 2021

BrainsWay Announces 100,000 Patients Treated with Deep Transcranial Magnetic Stimulation (Deep TMS)

The FDA cleared technology is a noninvasive treatment for depression, OCD, and smoking addiction CRESSKILL,...

March 24, 2021

BrainsWay Reports Fourth Quarter and Full-Year 2020 Financial Results and Operational Highlights

Conference call to be held tomorrow, March 25, 2021, at 8:30 AM ET CRESSKILL, N.J. and JERUSALEM, Israel,...

March 11, 2021

BrainsWay to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021

CRESSKILL, N.J., March 11, 2020 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the...

March 8, 2021

BrainsWay to Present at the Oppenheimer 31st Annual Healthcare Conference

CRESSKILL, N.J. and JERUSALEM, Israel, March 8, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...